NAFDAC: NAFDAC Deleject Needle Alert Error Clarified

• NAFDAC Public Alert 042/2026, concerning Deleject Disposable Needle Batch 240605, was erroneously published on the agency's website.
• The alert incorrectly reported the presence of whitish particulate matter in the specified batch of needles.
• The National Agency for Food and Drug Administration and Control had already investigated and satisfactorily resolved the issue several months prior to the alert's mistaken publication.
• Currently, there are no quality, safety, or regulatory concerns regarding Deleject Disposable Needle Batch 240605, according to NAFDAC.

As a direct consequence of the prior, thorough investigation and satisfactory resolution, NAFDAC has unequivocally confirmed that there are currently no outstanding quality, safety, or regulatory issues pertaining to Deleject Disposable Needle Batch No. 240605.

The National Agency for Food and Drug Administration and Control (NAFDAC) recently issued a significant clarification regarding an administrative error involving a public alert concerning medical devices. Specifically, Public Alert No. 042/2026, which pertained to the Deleject Disposable Needle Batch No. 240605, was erroneously uploaded to the agency's official website. This alert had reported the presence of whitish particulate matter within the specified batch of disposable needles, a finding that could potentially raise serious concerns for healthcare providers, patients, and the broader medical supply chain.

The agency's subsequent statement explicitly indicated that the publication of this particular alert was a mistake, as the underlying issue it referenced had already been thoroughly addressed and resolved internally. Such miscommunications from regulatory bodies can lead to unnecessary alarm and confusion, underscoring the critical importance of precise and timely information dissemination in maintaining public trust and market stability. The erroneous alert created a perception of an ongoing problem that, in reality, had long been settled.

NAFDAC's clarification emphasized that the reported issue of whitish particulate matter in Deleject Disposable Needle Batch No. 240605 was not a new or unresolved concern. In fact, the matter had previously undergone a comprehensive regulatory review and investigation process by the agency. This diligent examination, a standard procedure for ensuring Nigerian medical device compliance, led to a satisfactory resolution of the issue several months prior to the accidental publication of the alert.

The agency's proactive engagement in investigating and resolving potential quality and safety concerns is central to its mandate of safeguarding public health. The fact that the issue was deemed "satisfactorily resolved" indicates that NAFDAC found no lingering risks or non-compliance after its investigation, thereby closing the case from a regulatory standpoint well before the erroneous alert appeared online. This pre-existing resolution is a key detail in understanding the current status of the Deleject needles.

As a direct consequence of the prior, thorough investigation and satisfactory resolution, NAFDAC has unequivocally confirmed that there are currently no outstanding quality, safety, or regulatory issues pertaining to Deleject Disposable Needle Batch No. 240605. This NAFDAC regulatory clarification provides crucial assurance to all stakeholders, including importers, distributors, healthcare facilities, and legal professionals advising on Nigerian drug safety update matters. The erroneous alert, NAFDAC Public Alert 042/2026, should therefore be completely disregarded as it does not accurately reflect the current regulatory standing of the product.

For legal and compliance officers, this update is particularly significant, as it means that no current compliance action or client advice is warranted based on the specific, retracted alert. The initial concern regarding the NAFDAC Deleject needle alert error has been fully addressed and closed by the regulatory body, confirming that the product batch in question meets all necessary standards for safe use within Nigeria. This incident serves as a pertinent reminder of the dynamic nature of regulatory information and the imperative for continuous verification of public alerts to ensure accurate compliance assessments.

Lawyers and compliance officers should note that the NAFDAC public alert concerning Deleject Disposable Needles was issued in error and the underlying issue has been resolved. This clarifies that no current compliance action or client advice is required based on that specific, retracted alert.

Source: Original reporting via NAFDAC's regulatory clarification.